For any queries or a hard copy press kit, please contact us.
September, 2011
Aeon Astron will exhibit at the XXIX Congress of the ESCRS (European Society of Refractive & Cataract Surgeons). Join us at Booth B117 at the Reed Messe from Sep 17-21.
July, 2011
ologen® Symposium held at the World Glaucoma Congress. July 1st, Room 341, Palais des Congrès, Paris.
Scientific Program: Can MMC be replaced? ologen® Collagen Matrix for Eye Tissue Repair
Dr. Julio Lin. VP, Aeon Astron Europe
To Kill or To Guide? Introduction to ologen® Collagen Matrix
Prof. Salvatore Cillino. Department of Experimental Biomedicine and Clinical Neuroscience Ophthalmology Section Head, University of Palermo
Biodegradable collagen matrix implant vs. mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial
Prof. Jimmy Lai. Eye Insitute, The University of Hong Kong
Trabeculectomy with ologen and MMC
Prof. P Sathyan. Chief Glaucoma Services, Aravind Eye Care System
Topic: ologen in Trab - The Indian Experience & Practical Tips For Success
Moderated by Mr. Michael Lai. CEO, Aeon Astron Europe
January 2011
Aeon Astron Europe B.V. is the Glaucoma Industry member of WGA.
December 2010
Aeon Astron Europe B.V. is going to join four ophthalmology congress meetings in 2011: 1. AGS 2011, Dana Point(Mar.3-6); 2. WGC 2011, Paris(June29-July 2); 3. XXIX Congress of the ESCRS, Vienna; 4. AAO, Joint the Academy for 2011, Orlando(Oct.22-25). Please refer to "Meetings & exhibits" for further information.
August 2010
Bio artificial light in the darkness. August 14, 2010. Biotech Company Aeon Astron Europe develops artificial corneas that could help millions of blind people around the world to see. Important Note: This editorial has been published in Dutch in the Financial Daily News paper on 14 August 2010. The copyright is exclusively to Lien van der Leij , journalist of the Financial Daily news paper (het Financieele dagblad & www.FD.nl). Website: http://www.fd.nl/artikel/20040544/biokunstmatig-licht-duisternis
February 2010
Aeon Astron Europe B.V. is going to join four ophthalmology congress meetings in 2010: WOC 2010 in Berlin (June 4-9); XXVIII Congress of the ESCRS in Paris (Sep. 4-8); 25th APAO congress in Beijing (Sep.16-20); and AAO 2010 Joint Meeting with the MEACO in Chicago (Oct.16-19). Please refer to "Meetings & exhibits" for further information.
April 2010
ologen® is paid by the Medicare System in Sweden since 2010.
June 2010
Bio artificial cornea regeneration research may bring light to the blind- June 21, 2010, Leiden, the Netherlands: Aeon Astron Europe BV (AAE), enters an agreement with the Department of Ophthalmology of the Leids Universitair Medisch Centrum (LUMC) to develop an artificial biocornea to restore sight for corneal blindness.
January 2010
ologen® is reimbursed by the General Insurance Agency in Czech since 2010.
August 3, 2009
Aeon Astron Europe BV hereby announces that it has received US FDA 510K clearance letter for its collagen matrix used for the management of wounds. The issued number is K080868. For further information, please visit http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080868.pdf
Nov. 18, 2008
The brand oculusgen has been changed to ologen
Sep. 10, 2008
Eye tissue repair to be introduced by Aeon Astron Europe B.V.
July 14, 2008
Body Organ Biomedical Corp. announces the prototype of bio cornea and enters the animal studies.
June 28, 2008
World Ophthalmology Congress 2008 acceptted poster: "Study of the safety and effectiveness between ologen™ collagen matrix implant and Mitomycin-C in standard glaucoma filtration surgery" by Dr. Syed Imtiaz Ali.
June 28, 2008
World Ophthalmology Congress 2008 acceptted poster: "Trabeculectomy with Subconjunctival Biodegradable Implant" by Dr. Piyush Jansari